Psychometric properties of the 4-week version of the Borderline Personality Disorder Severity Index-5

Open Access
Authors
  • Shanna van Trigt
  • Mariana Mendoza-Alvarez
  • Tanja van der Zweerde
  • Livia De Picker
  • Annemieke van Straten
  • Arnoud Arntz
  • Hein J.F. van Marle
Publication date 11-2025
Journal Comprehensive Psychiatry
Article number 152634
Volume | Issue number 143
Number of pages 9
Organisations
  • Faculty of Social and Behavioural Sciences (FMG) - Psychology Research Institute (PsyRes)
Abstract
This study evaluated the psychometric properties of a new version of the Borderline Personality Disorder Severity Index-5 that assesses BPD symptom severity over the course of 4 weeks instead of the standard 3 months: the BPDSI-5-4wk. Reliability and validity were evaluated in a mixed sample of patients with BPD (n = 92), patients with avoidant personality disorder (APD) as clinical control group (n = 16), and a non-patient control group (n = 20). The study demonstrated very high interrater agreement and test-retest reliability and acceptable to excellent internal consistencies of the BPDSI-5-4wk. Confirmatory factor analysis supported its assumed nine-factor structure. The BPDSI-5-4wk also showed very good construct (i.e. known-group) validity, as well as criterion-related (i.e. concurrent) validity when correlating the BPDSI-5-4wk with the BPDSI-5 (3-month version), the structured clinical interview for DSM personality disorders (SCID-5-P), and several other BPD- and other mental health-related self-report questionnaires. We additionally derived cut-off scores with high sensitivity and specificity for distinguishing BPD from clinical controls (21.02, 85 % sensitivity, 94 % specificity), from non-patient controls (10.50, 98 % sensitivity, 100 % specificity), and from both control groups combined (17.26, 93 % sensitivity, 92 % specificity). A reliable change criterion of 5.88 was established. Preliminary trial data additionally showed the BPDSI-5-4wk's sensitivity to change. The strong reliability and validity of the BPDSI-5-4wk support its value for detailed, dimensional assessment of BPD symptom severity over shorter time frames. This will facilitate frequent treatment response evaluations, rapid indication of follow-up treatment, and better alignment with shorter intervention and follow-up periods in clinical trials.
Document type Article
Language English
Published at https://doi.org/10.1016/j.comppsych.2025.152634
Other links https://www.scopus.com/pages/publications/105015487280
Downloads
Supplementary materials
Permalink to this page
Back